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ABSTRACT 
Cough formulations were observed to contain some chemical substances that have been associated 
with antimicrobial property, namely: menthol, honey, citric acid and volatile oils. A prolonged use of 
such formulations by patients was therefore considered a health risk on the normal bacterial flora. 
Nine cough formulations denoted by letter codes along with simple syrup B.P., absolute alcohol and 
sterile distilled water as controls, were investigated for relative antimicrobial activity on some normal 
flora bacteria by the agar-cup diffusion method. The respective individual single brands of cough 
formulation with the exception of one brand exhibited inhibitory activity against 5 - 1 2  bacterial 
isolates including Escherichia coli, Klebsiella spp, Streptococcus faecalis, Strep. pneumoniae, Strep. 
viridians, Proteus mirabilis, Staphylococcus aureus and Pseudomonas aeruginosa. 
Simple Syrup B.P. and sterile distilled water did not exhibit any antibacterial activity while the 
absolute alcohol exerted activity only on Staph aureus. The antimicrobial activity recorded for the 
cough formulations could cause a depletion of the normal bacterial flora following a prolonged use 
of the formulations tested, hence, the attendant health risk of depressed natural immune system of 




Cough preparations are drugs, useful for 
the initiation of cough, serving either as 
cough suppressants in cases of non-
productive cough associated with mucus 
secretions in the throat. Cough is 
recognized as an important physiological 
protective mechanism, particularly, while 
serving to clear the respiratory passage of 
foreign materials and excess secretions(1). 
Cough could however assume a 
pathological status when it presents as a 
symptom of an underlying disorder and 
becomes chronic. In such situations, the 
use of an appropriate cough formulation 
becomes highly imperative, though with 
the attendant implications in the events of 
a prolonged use. Cough formulations 
usually contain mixtures of 
antihistamines, decongestants, 





their forms of activity but so far without 
established antimicrobial activity. Besides 
these combinations in cough mixtures, 
there are other chemical substances that 
have inhibitory activity on 
microorganisms, namely: menthol, citric 
acid, honey and volatile oils e.g. 
peppermint oil, aniseed and menthol. 
Ammonium salts and sodium citrate may 
also be present which along with citric 
acid would affect the pH of the 
formulations. In particular, honey and 
volatile oils (mixtures of esters, aldehydes, 
alcohols, ketones and terpenes) have been 
reported by various workers to have 
pronounced antimicrobial activity(2,3,4). 
Certain herbs, also with demonstrable 
antimicrobial activity are known to be 
included in cough formulations e.g. 
bloodroot, eucalyptus, red clover and 
others. The presentation of cough 
formulations as oral preparations 
implicates their intimate contact with the 
normal bacterial flora against which the 
antimicrobial property of the relevant 
components of the formulations may be 
directed. Such bacteria are recognized for 
their role in the innate immune response 
of the body. In spite of this recognition, 
research effort has hitherto not been 
directed at a deliberate investigation of 
the extent of the antimicrobial activity of 
the cough formulations vis-a- vis its health 
risk on the normal bacterial flora 
consequent upon their prolonged 
administration. It was against this 
background that this study has been 
designed. 
MATERIALS AND METHODS 
BACTERIOLOGY 
Bacterial isolates of Staphylococcus aureus (4 
isolates), Escherichia coli (2 isolates), Klebsiella 
sp. 1 isolate), Streptococcus faecalis (1 isolate), 
Strep. viridians, Strep pneumoniae (2 isolates), 
Proteus mirabilis (3 isolates) and Pseudomonas 
aeruginosa (3 isolates) were collected from 
different clinical sources of throat, wound 
and sputum. They were confirmed by some 
established conventional methods: Salt 
tolerance on Mannitol Salt Agar, Catalase, 
Oxidase and Coagulase tests as well as 
Gram staining(10). The bacteria were then 
preserved as slant cultures at 4°C in a 
refrigerator.
COUGH FORMULATION AND OTHER 
CHEMICALS 
Nine cough formulations were purchased 
from some Pharmacy st
ores in Ibadan, Nigeria. They were given 
letter codes as stated along with their 
respective chemical ingredients in Table 1. 
Simple   Syrup   B.P:   It was   prepared   as   
described   in   the official monograph (B.P. 
1980). Absolute alcohol: It was purchased 
from a local chemical supplier based in 
Ibadan, Nigeria.  
ANTIMICROBIAL SUSCEPTIBILITY TEST 
The agar-cup diffusion as described by 
Singleton(5) was used for assessing the 
susceptibility of the bacterial isolates to each 





Simple Syrup B.P., absolute alcohol and 
sterile distilled water as controls. MS-2 that 
contained only ammonium chloride and 
ammonium bicarbonate as chemical 
additives was brought into mixture in ratio 
1:1 with each of the other 7 cough 
formulations. The resulting mixtures were 
then similarly assessed for antimicrobial 
activity against the same bacterial isolates. 
Simply, the method involved digging holes 
(or wells) in solid culture media that have 
been seeded with each of the bacterial 
isolates. The wells were then filled with the 
respective cough formulations and the 
controls. After a 24-hrs period of incubation 
at 37°C, zones of growth inhibition 
produced were measured to determine 
bacterial sensitivity or resistance (Tables 3 & 
4). 
RESULTS 
Amongst the 9 cough formulations tested 
(Table 1), MS - 1 brand in plastic container 
did not show antimicrobial activity against 
any one of the bacterial isolates tested, just 
like the controls except the absolute alcohol 




 aureus isolate (Table 2). The Zones of 
growth inhibition produced by the cough 
formulations varied from 8mm to 30mm.  
TL brand had the widest spread of 
antibacterial activity against 13 isolates 
including at least one isolate of every 
bacterial sp. tested, followed by CF brand (9 
isolates), CT brand (8 isolates), BN brand (6 
isolates), EZ and MS - 2 brands (5 isolates 
each) and, ZP and DK brands (4 isolates 
each) (Table 2). However, decreased 
antimicrobial activity was noticeable for 
the mixtures of 7 cough formulations each 
with MS - 2 brand. Exceptionally, BN, CF, 
ZD, CF and DK brands and also absolute 
alcohol, each in combination with the MS - 
2 brand produced higher activity against 
Staph. aureus than when each of the 
formulations was tested alone. Similar 
trend obtained with TL and CF brands 
against one Proteus mirabilis isolate (Table 3). 
Remarkably, Simple Syrup B. P. in 
combination with the same MS - 2 brand 
exhibited antistreptococcal activity which 








TABLE 1: THE COUGH SYRUPS (IN LETTER CODES) AND THEIR CHEMICAL CONSTITUENTS AS 
STATED ON THEIR LABELS. 
EZ   : Diphenhydramine, ammonium Chloride, Sodium citrate and 
                          menthol. 
BN : Diphenhydramine and ammonium chloride 
CT : Ammonium chloride, Ipecacuanha liquid extract, Liquorice 
 extract, pepermint oil and aniseed oil. 
ZD : Bromhexine,     dextromethorphan,     ammonium     chloride, 
 menthol, flavoured syrupy base. 
CF : Chlorphemiramine,   ammonium   chloride,   Sodium   citrate, 
 menthol and ephedrine. 
DK : Diphenhydramine, bronhexine, ammonium chloride, Sodium 
 Citrate, and menthol. 
TL : Diphenhydramine,  ammonium chloride,  trisodium citrate, 
  Citric acid, menthol and flavoured Syrup base.  
MS- 1:         Ammonium Chloride and ammonium bicarbonate (in plastic 
 container).  
MS - 2:         Ammonium Chloride and ammonium bicarbonate (in glass 





TABLE 2: THE ANTIMICROBIAL ACTIVITY OF COUGH FORMULATIONS ON SOME CLINICAL 
ISOLATES 
 
Zones of growth inhibition (mm) 
ORGANISM EZ BN CT ZD CF DK TL MS-1 MS-2 






















SA1 15* - 12 - - - - - 15 - - - 
SA2 15 - 16 - - - - - 10 - - - 
SA3 - - - - - 10 12 - - - - - 
SA4 Typed 17 16 16 - 18 16 17 - - - - - 
PA1 15 - 19 30 - 15 - - 14 - - - 
PA2 - - - - 
17 
(RM) 
- 12 - - - - - 
PA3 Typed - - - - 
14 
(RM) 
- 13 - - - - - 
PM1 - - 12 30 - - - - 12 - - - 
PM2 - - 11 30 - - - - 12 - - - 
PM3 - - - - - - 13 - - - - - 
EC1 - - - - 
29 
(RM) 
- 13 - - - - - 





14 - 13 - - - - - 
SPI - - - - 
9 
(IM) 
- 12 - - - - - 


















- 13 - - - - - 
KL Typed - 14 - - 13 15 16 - - - - - 
KEY 
SA = Staph.  aureus                                    SV= Strep. viridians 
PA = Pseud. aeruginosa                        SF = Strep. faecalis 
PM = Proteus mirabilis  KL = Klebsiella sp. 
EC = Esch. coli  Rm = Resistant mutant (few discrete colonies 
              within the Zone) 
SP = Strep. Pneumoniae  IM = Intermediate 
-    = Resistant (No Zone of growth inhibition) 





TABLE 3: ANTIMICROBIAL ACTIVITY OF COUGH FORMULATIONS EACH IN COMBINATION WITH 
MS - 2 BRAND ON SOME CLINICAL ISOLATES 
 










































15* 14 - 14 12 15 - - 10 - 
SA2 
 
15 18 14 16 14 20 - - 13 - 
SA3 
 
- - - - - - 10 - - - 
SA4 
 
- - - - - - - - - - 
PA1 
 
- - - - - - - - - - 
PA2 
 
- - - - - - - - - - 
PA3 Typed 
 
- - - - - - - - - - 
PM1 
 
- - - - - - - - - - 
PM2 
 
- - - - - - - - - - 
PM3 
 
- - - - 24 - 25 - - - 
EC1 
 
- - - - - - - - - - 
EC2 
 
- - - - - - - - - - 
SP1 
 





- - - - - - - - - - 
SV 
 










- - - - - - - - - - 
KEY 
SA = Staph. aureus                       SF = Strep. faecalis      SV = Strep. viridians 
PA = Pseud. aeruginosa               KL = Klebsiella sp. 
PM = Proteus mirabilis                IM = Intermediate 
EC = Esch. coli                             - = Resistant (No Zone of growth inhibition) 






The inhibitory effect of certain chemical 
substances - menthol, citric acid, honey, 
volatile oils and others, contained in cough 
formulations on microorganism is well 
recognized (6,7,8,9) yet, a deliberate effort 
directed at determining the extent of such 
antimicrobial activity offered by whole 
cough formulations and its health risk with 
respect to the human body normal bacterial 
flora in the event of their prolonged use by 
patients, has hitherto been lacking. It is 
interesting to note in this study the varying 
levels of antimicrobial activity recorded for 
the cough formulations tested individually 
but remarkably for TL, CF, CT and BN 
brands. Of further interest was the 
observation that 5 cough formulations (DK, 
CF, ZD, CT and BN brands) had their 
antistaphylococcal activity increased when 
combined each with MS - 2 brand. This 
improved combination antibacterial effect 
was also observed for TL and CF brands 
against Streptococcus pneumoniae as well as 
for Sterile Syrup B.P. Remarkably none of 
Pseud. and Esch. spp. 
 was sensitive to any one of the cough 
formulations in combination with MS - 2. 
The bacteria used in this study are among 
the normal bacterial flora of man, occurring 
variously in mouth, throat, pharynx and 
gut within which they perform host body 
defense against microbial infections(5). This 
indication suggests a depletion of these 
microbes by the antimicrobial activity of 
cough formulations, particularly, when 
subjected to prolonged use by patients. The 
health risk involved becomes worrisome 
when cough formulations have to be taken 
concomitantly with some antibiotics usually 
in the conditions of microbial infections that 
may present cough as a symptom. The 
awareness generated in this study on the 
health risk in the prolonged use of cough 
formulations should form part of health 
education to patients. 
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